Equities
Health CareMedical Equipment and Services
  • Price (EUR)43.70
  • Today's Change-0.20 / -0.46%
  • Shares traded4.83k
  • 1 Year change-30.63%
  • Beta0.1081
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

  • Revenue in EUR (TTM)252.30m
  • Net income in EUR12.15m
  • Incorporated2018
  • Employees1.47k
  • Location
    Stratec SEGewerbestr. 37BIRKENFELD 75217GermanyDEU
  • Phone+49 708279160
  • Fax+49 70 827916999
  • Websitehttps://www.stratec.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SBSX:GER since
announced
Transaction
value
Natech Plastics IncDeal completed07 Jun 202307 Jun 2023Deal completed-29.63%30.00m
Data delayed at least 15 minutes, as of May 16 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medistim ASA45.64m8.82m275.90m152.0031.237.4525.326.045.605.6029.0123.481.030.77656.153,492,704.0019.9522.9324.0728.5279.0278.2519.3120.642.99--0.020675.257.0010.06-8.9112.720.03314.87
Nyxoah SA4.35m-43.21m276.30m147.00--2.82--63.55-1.55-1.550.15553.420.03220.78912.0629,618.53-31.98-23.73-35.88-25.9861.9162.42-993.86-1,469.594.50--0.1147--40.99---38.39--100.58--
BICO Group AB194.04m-138.03m277.98m837.00--1.09--1.43-22.34-26.3931.7342.970.33982.334.142,555,996.00-24.19---27.59--50.48---71.20--1.95-13.810.3933--6.09---1,889.33------
Lumibird SA203.56m7.13m294.32m1.05k36.811.5212.031.450.35590.35599.148.620.52381.094.05193,497.101.833.132.443.9961.6861.763.505.891.622.470.42870.006.6015.12-37.23-2.4718.34--
COLTENE Holding AG246.48m12.13m319.18m1.20k26.283.2416.721.292.002.0040.6216.211.331.406.58201,937.606.5310.4810.9018.7464.2462.684.927.470.80455.620.317279.94-9.133.54-54.05-6.81-7.72-7.79
IVF Hartmann Holding AG150.24m15.38m331.45m304.0021.552.1615.792.216.316.3161.6363.070.80153.088.46486,687.508.217.299.998.9053.9053.2910.248.303.89--0.005652.16-1.792.0934.951.49-14.8326.82
Ion Beam Applications SA428.72m-9.11m430.01m1.99k--3.90178.351.00-0.3139-0.313914.723.640.7022.542.65215,869.60-1.491.55-5.924.3231.3635.23-2.122.380.71031.400.281464.8318.6710.74-250.40---8.06--
Avon Protection PLC224.07m-15.07m443.89m928.00--3.11109.771.98-0.431-0.37856.414.050.70052.635.48207,106.50-4.71-1.07-5.39-1.2935.2335.51-6.73-1.621.802.920.3822---7.481.85-387.72---1.66-7.86
CellaVision AB60.83m12.13m473.17m223.0039.027.2630.297.785.925.9229.6931.810.7571.688.453,106,469.0015.0915.3017.3418.2467.5269.0319.9419.982.2166.290.0688110.185.9413.1710.128.0030.458.45
Safilo Group SpA1.02bn-24.65m510.59m3.83k--1.3517.530.4983-0.0596-0.05962.480.91651.131.804.91267,693.80-2.87-7.06-4.47-11.3057.1652.70-2.55-6.871.101.940.2848---4.832.39-145.51---15.50--
Stratec SE252.30m12.15m531.30m1.47k43.742.3217.582.110.99910.999120.7518.860.59061.345.11165,771.402.847.073.558.2025.6027.324.819.700.80294.410.382640.81-4.636.88-55.293.30-2.16-7.68
Advanced Medical Solutions Group plc147.14m18.52m543.70m850.0029.621.9117.483.700.07240.07240.57551.120.44261.755.34148,482.405.576.546.047.0655.5756.7512.5914.824.00--0.036125.851.514.23-22.14-6.7115.6612.32
Synsam AB (publ)507.12m26.71m673.72m3.41k25.063.087.441.332.092.0939.6216.960.73562.2213.121,730,149.003.86--5.27--75.50--5.25--0.4922--0.5675--11.90---5.18------
medmix AG494.13m304.64k682.98m2.66k1,626.751.4312.011.380.010.0111.9111.410.46063.656.05183,070.000.06632.060.08462.4932.4136.380.14394.161.232.920.424467.701.991.40-97.41-64.3612.01--
Paul Hartmann AG2.35bn28.42m710.28m10.17k24.990.6685.230.30188.008.00662.57299.401.182.025.72231,438.001.643.872.265.3456.0156.711.392.981.164.870.186542.751.802.12-21.37-18.495.952.71
Revenio Group Oyj96.68m19.01m763.61m216.0039.727.6233.277.900.72050.72053.663.760.70695.507.60447,574.1013.9014.3316.7717.9051.0150.7319.6621.131.7928.490.152155.81-0.412525.80-12.1518.7217.676.30
Data as of May 16 2024. Currency figures normalised to Stratec SE's reporting currency: Euro EUR

Institutional shareholders

28.39%Per cent of shares held by top holders
HolderShares% Held
Brown Capital Management LLCas of 31 Dec 2023903.15k7.43%
Invesco Advisers, Inc.as of 11 Aug 2023609.88k5.02%
Juno Investment Partnersas of 31 Dec 2023374.59k3.08%
Threadneedle Asset Management Ltd.as of 12 May 2023346.29k2.85%
The Vanguard Group, Inc.as of 05 Apr 2024255.94k2.11%
Candriam Belgium SAas of 29 Mar 2024224.46k1.85%
Comgest SAas of 31 Jan 2024213.64k1.76%
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024187.44k1.54%
Harding Loevner LPas of 31 Dec 2023168.40k1.39%
Allianz Global Investors GmbHas of 30 Apr 2024168.07k1.38%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.